A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs

For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been attempted with overlooked or overestimated efficacy owing to limited clinical evidence. Most early clinical trials...

Full description

Bibliographic Details
Main Authors: Po-Lin Chen, Nan-Yao Lee, Cong-Tat Cia, Wen-Chien Ko, Po-Ren Hsueh
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19
SARS-CoV-2
treatment
anti-viral agents
interleukin-6 inhibitors
convalescent plasma
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.584956/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.584956/full

Similar Items